Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Antalium Inc.

Division of PainCeptor Pharma Corp.

Latest From Antalium Inc.

Selected Start-Ups Founded in 1999 (3/99)

We summarize the technologies of Antalium Inc., Enzacta Ltd., IgX Oxford Hepatitis Corp., L2 Diagnostics Inc. and Tempus Resource Management.

BioPharmaceutical Medical Device

Antalium Inc.

In recent years, insights into the molecular biology of pain have given drug developers new targets, and companies are thronging to the field in the hope of developing side-effect free, non-narcotic analgesics. With the aim of developing novel drugs for pain based on novel ion channels, McGill University has spun-off Antalium Inc.


Biotechnology North of the Border

A venture-backed Canadian biotechnology industry is in its infancy, but faced with hostile capital markets, start-ups need clear exit plans. Consolidation's already started.

BioPharmaceutical Business Strategies
See All

Company Information

  • Industry
  • Biotechnology
  • Pharmaceuticals
  • Therapeutic Areas
  • Neurology, Nervous System
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • Canada
  • Parent & Subsidiaries
  • PainCeptor Pharma Corp.
  • Senior Management
  • Kazimierz Babinski, PhD, CEO
  • Contact Info
  • Antalium Inc.
    Phone: (514) 842-9848
    1550 Metcalfe St.
    Ste. 502
    Montreal, H3S 1X6